Curaevia
ActiveSummary
The annual accounts of Curaevia for financial year 2026 show a net loss of 83% of the equity at the start of that year. The 2026 annual accounts show equity of €4,865 and a net result of -€24,301. Equity is shrinking by about 16% per year across the filed financial years. Its solvency ranks better than 7% of 406 sector peers (NACE 62, financial year 2026). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.7% (low).
Articles of association
- Who signsWho may bind the company towards others, for example by signing a contract.
- “- de vennootschap PHARMALEGAL BV, bestuurder, vertegenwoordigd door haar vaste vertegenwoordiger de heer Georges De Feu; - de heer Pieter…”
Read from the deeds: 1 provision, deed of 24-07-2025